Literature DB >> 28386827

Pediatric epilepsy - an Indian perspective.

Vrajesh Udani1.   

Abstract

Prevalence studies from India suggest that epilepsy prevalence is similar to developed nations. Neurocysticercosis (NCC) predominates as an etiology. A large treatment gap is still a public health problem. Benign epilepsies and West syndrome appear to be underrepresented in studies on classification of seizures/syndromes. Febrile seizures prevalence in India is similar to other countries and appear to be as benign. Risk factors of intractable epilepsy (IE) in Indian studies include early age of onset, neurodevelopmental abnormalities and certain seizure types. Perinatal injuries underlie many IE. Many IE are not truly intractable and respond to simple therapeutic measures. The ketogenic diet and surgery are other methods now being used in Indian centers. Neurocysticercosis and neonatal hypoglycemic brain injury, two widely prevalent etiologies are reviewed in detail.

Entities:  

Keywords:  Childhood epilepsy; Hypoglycemia; India; Neurocysticercosis

Year:  2005        PMID: 28386827     DOI: 10.1007/BF02724012

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  36 in total

1.  Epileptic encephalopathies of early childhood.

Authors:  A Seth; S Aneja; V Taluja
Journal:  Indian Pediatr       Date:  2001-04       Impact factor: 1.411

Review 2.  Epidemiology of epilepsy in India.

Authors:  N E Bharucha
Journal:  Epilepsia       Date:  2003       Impact factor: 5.864

3.  Guidelines for the management of convulsions with fever. Joint Working Group of the Research Unit of the Royal College of Physicians and the British Paediatric Association.

Authors: 
Journal:  BMJ       Date:  1991-09-14

Review 4.  Febrile seizures: treatment and prognosis.

Authors:  F U Knudsen
Journal:  Epilepsia       Date:  2000-01       Impact factor: 5.864

5.  Prevalence and pattern of epilepsy in India.

Authors:  R Sridharan; B N Murthy
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

6.  Edema associated with calcified lesions in neurocysticercosis.

Authors:  T E Nash; N J Patronas
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

7.  Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures.

Authors:  Ravi Kant Mall; Atul Agarwal; Ravindra Kumar Garg; Alok Mohan Kar; Rakesh Shukla
Journal:  Epilepsia       Date:  2003-11       Impact factor: 5.864

8.  Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis.

Authors:  Pratibha Singhi; Vivek Jain; Narendra Khandelwal
Journal:  J Child Neurol       Date:  2004-05       Impact factor: 1.987

9.  Difficult to control epilepsy in childhood--a long term study of 123 cases.

Authors:  V P Udani; V Dharnidharka; A Nair; M Oka
Journal:  Indian Pediatr       Date:  1993-10       Impact factor: 1.411

10.  Shortcomings in the pharmacotherapy of epileptic children in Bombay, India.

Authors:  S C Karande; S S Dalvi; N A Kshirsagar
Journal:  J Trop Pediatr       Date:  1995-08       Impact factor: 1.165

View more
  3 in total

1.  Effect of Folic Acid Supplementation on Seizure Control in Epileptic Children Receiving Long Term Antiepileptic Therapy.

Authors:  Bindu Deopa; Manish Parakh; Pawan Dara; Vikas Payal; Kapil Chordiya; Ankit Panday; Sumeet Singh; Devesh Parashar
Journal:  Indian J Pediatr       Date:  2018-01-25       Impact factor: 1.967

2.  An association analysis of reelin gene (RELN) polymorphisms with childhood epilepsy in eastern Indian population from West Bengal.

Authors:  Shruti Dutta; Prasanta K Gangopadhyay; Swagata Sinha; Anindita Chatterjee; Saurabh Ghosh; Usha Rajamma
Journal:  Cell Mol Neurobiol       Date:  2010-08-10       Impact factor: 5.046

3.  Neurological disorders in children and adolescents.

Authors:  Tapas K Banerjee; Avijit Hazra; Atanu Biswas; Jayanta Ray; Trishit Roy; Deepak K Raut; Arijit Chaudhuri; Shyamal K Das
Journal:  Indian J Pediatr       Date:  2008-12-04       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.